EGFR and cancer: In both normal tissue cells and cancer cells, ITGB1 participates in the pathways that control cell proliferation or apoptosis [106]: in normal cells, multiple receptors including EGFR, c-Met, PDGFR, and VEGFR directly interact with integrins to activate the cell proliferative activity, and do not involve their normal ligands.